应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ADPT Adaptive Biotechnologies Corp
休市中 02-14 16:00:00 EST
8.33
-0.19
-2.23%
盘后
8.52
+0.19
+2.22%
19:23 EST
最高
8.74
最低
8.19
成交量
200.55万
今开
8.60
昨收
8.52
日振幅
6.51%
总市值
12.31亿
流通市值
8.14亿
总股本
1.48亿
成交额
1,685万
换手率
2.05%
流通股本
9,775万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
异动解读 | Adaptive Biotechnologies Corp盘中大涨9.93%,机构看好前景上调目标价
异动解读 · 02-13 19:16
异动解读 | Adaptive Biotechnologies Corp盘中大涨9.93%,机构看好前景上调目标价
Scotiabank:维持Adaptive Biotechnologies(ADPT.US)评级,由跑赢大盘调整至跑赢大盘评级, 目标价由10.00美元调整至12.00美元。
金融界 · 02-13 19:11
Scotiabank:维持Adaptive Biotechnologies(ADPT.US)评级,由跑赢大盘调整至跑赢大盘评级, 目标价由10.00美元调整至12.00美元。
Adaptive Biotechnologies Corporation盘中异动 早盘急速上涨5.03%报7.93美元
市场透视 · 02-13 15:43
Adaptive Biotechnologies Corporation盘中异动 早盘急速上涨5.03%报7.93美元
美国研究综述-爱迪生国际公司、Onestream 公司、Vertex 制药公司
路透中文 · 02-12 07:21
美国研究综述-爱迪生国际公司、Onestream 公司、Vertex 制药公司
美国研究综述-爱迪生国际公司、Onestream 公司、Vertex 制药公司
路透中文 · 02-12 07:21
美国研究综述-爱迪生国际公司、Onestream 公司、Vertex 制药公司
Adaptive Biotechnologies 公司报告截至 12 月 31 日的季度业绩 - 收益摘要
路透中文 · 02-11
Adaptive Biotechnologies 公司报告截至 12 月 31 日的季度业绩 - 收益摘要
Adaptive Biotechnologies 2024年第四季度GAAP每股亏损$(0.23)优于预期$(0.26),销售额$47.459百万超过预期$46.034百万
财报速递 · 02-11
Adaptive Biotechnologies 2024年第四季度GAAP每股亏损$(0.23)优于预期$(0.26),销售额$47.459百万超过预期$46.034百万
Adaptive Biotechnologies Corporation盘中异动 股价大跌5.31%报7.42美元
市场透视 · 02-10
Adaptive Biotechnologies Corporation盘中异动 股价大跌5.31%报7.42美元
Adaptive Biotechnologies Corporation盘中异动 快速上涨5.29%
市场透视 · 02-05
Adaptive Biotechnologies Corporation盘中异动 快速上涨5.29%
Adaptive Biotechnologies Corporation盘中异动 下午盘急速下跌5.00%报7.32美元
市场透视 · 02-04
Adaptive Biotechnologies Corporation盘中异动 下午盘急速下跌5.00%报7.32美元
Adaptive Biotechnologies Corporation盘中异动 股价大涨5.19%报8.11美元
市场透视 · 01-30
Adaptive Biotechnologies Corporation盘中异动 股价大涨5.19%报8.11美元
Adaptive Biotechnologies Corporation盘中异动 股价大跌5.03%报7.46美元
市场透视 · 01-29
Adaptive Biotechnologies Corporation盘中异动 股价大跌5.03%报7.46美元
高盛:维持Adaptive Biotechnologies(ADPT.US)评级,由中性调整至中性评级, 目标价由5.50美元调整至7.50美元。
金融界 · 01-28
高盛:维持Adaptive Biotechnologies(ADPT.US)评级,由中性调整至中性评级, 目标价由5.50美元调整至7.50美元。
Adaptive Biotechnologies Corporation盘中异动 快速跳水5.01%报7.59美元
市场透视 · 01-27
Adaptive Biotechnologies Corporation盘中异动 快速跳水5.01%报7.59美元
Adaptive Biotechnologies Corporation盘中异动 早盘急速拉升5.10%
市场透视 · 01-22
Adaptive Biotechnologies Corporation盘中异动 早盘急速拉升5.10%
Adaptive Biotechnologies Corporation盘中异动 股价大涨5.51%报7.19美元
市场透视 · 01-21
Adaptive Biotechnologies Corporation盘中异动 股价大涨5.51%报7.19美元
Adaptive Biotechnologies Corporation盘中异动 快速下挫5.31%
市场透视 · 01-16
Adaptive Biotechnologies Corporation盘中异动 快速下挫5.31%
Adaptive Biotechnologies Corporation盘中异动 大幅上涨8.57%
市场透视 · 01-15
Adaptive Biotechnologies Corporation盘中异动 大幅上涨8.57%
Adaptive Biotechnologies Corporation盘中异动 下午盘股价大跌5.11%
市场透视 · 01-14
Adaptive Biotechnologies Corporation盘中异动 下午盘股价大跌5.11%
Adaptive Biotechnologies Corporation盘中异动 临近午盘快速下跌5.08%
市场透视 · 01-13
Adaptive Biotechnologies Corporation盘中异动 临近午盘快速下跌5.08%
加载更多
公司概况
公司名称:
Adaptive Biotechnologies Corp
所属市场:
NASDAQ
上市日期:
--
主营业务:
Adaptive Biotechnologies Corporation于2009年9月8日在华盛顿州注册成立。公司正通过利用适应性免疫系统的固有生物学,向疾病的诊断和治疗转变,推进免疫驱动医学领域。该公司认为,适应性免疫系统是大自然对大多数疾病进行的最精细的诊断和治疗,但无法解码使医学界无法充分利用其能力。该公司的免疫医学平台应用专有技术来读取患者免疫系统的多种遗传密码,并准确了解如何检测和治疗该患者的疾病。该公司的免疫医学平台应用专有技术来读取患者免疫系统的多种遗传密码,并准确了解如何检测和治疗该患者的疾病。该公司在动态临床免疫组学数据库中捕捉到这些见解,该数据库以计算生物学和机器学习为基础,用于开发和商业化公司正在为每位患者量身定制的临床产品和服务。
发行价格:
--
{"stockData":{"symbol":"ADPT","market":"US","secType":"STK","nameCN":"Adaptive Biotechnologies Corp","latestPrice":8.33,"timestamp":1739566800000,"preClose":8.52,"halted":0,"volume":2005472,"hourTrading":{"tag":"盘后","latestPrice":8.515,"preClose":8.33,"latestTime":"19:23 EST","volume":43017,"amount":359638.52,"timestamp":1739579015832},"delay":0,"floatShares":97751622,"shares":147773744,"eps":-1.084229,"marketStatus":"休市中","change":-0.19,"latestTime":"02-14 16:00:00 EST","open":8.6,"high":8.74,"low":8.185,"amount":16846361.883456,"amplitude":0.065141,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.084229,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1739869200000},"marketStatusCode":7,"adr":0,"listingDate":1561608000000,"exchange":"NASDAQ","adjPreClose":8.52,"preHourTrading":{"tag":"盘前","latestPrice":8.6,"preClose":8.52,"latestTime":"09:29 EST","volume":292,"amount":2501.801104,"timestamp":1739543372888},"postHourTrading":{"tag":"盘后","latestPrice":8.515,"preClose":8.33,"latestTime":"19:23 EST","volume":43017,"amount":359638.52,"timestamp":1739579015832},"volumeRatio":1.120786,"impliedVol":0.8161,"impliedVolPercentile":0.255},"requestUrl":"/m/hq/s/ADPT","defaultTab":"news","newsList":[{"id":"1155355441","title":"异动解读 | Adaptive Biotechnologies Corp盘中大涨9.93%,机构看好前景上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1155355441","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155355441?lang=zh_cn&edition=full","pubTime":"2025-02-14 03:16","pubTimestamp":1739474195,"startTime":"0","endTime":"0","summary":"Adaptive Biotechnologies Corp(ADPT)股价今日盘中大涨9.93%,引发市场关注。\n\n股价上涨主要受到机构评级目标价上调的利好消息驱动。投行Scotiabank维持对ADPT的评级为\"跑赢大盘\",并将目标价从10美元上调至12美元。此前,ADPT在生物技术行业内表现出较强的发展势头。\n\n作为一家专注于免疫驱动医学的生物科技公司,ADPT的临床诊断产品clonoSEQ已获FDA批准,可用于检测和监测多种血液肿瘤患者的最小残留病情。ADPT正着力将该产品推广至更广泛的淋巴癌适应症。公司在血液肿瘤诊断领域的创新有望为长期增长注入新动能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Adaptive Biotechnologies Corp盘中大涨9.93%,机构看好前景上调目标价","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ADPT"],"gpt_icon":0},{"id":"2511951579","title":"Scotiabank:维持Adaptive Biotechnologies(ADPT.US)评级,由跑赢大盘调整至跑赢大盘评级, 目标价由10.00美元调整至12.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511951579","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511951579?lang=zh_cn&edition=full","pubTime":"2025-02-14 03:11","pubTimestamp":1739473875,"startTime":"0","endTime":"0","summary":"Scotiabank:维持Adaptive Biotechnologies(ADPT.US)评级,由跑赢大盘调整至跑赢大盘评级, 目标价由10.00美元调整至12.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/14031148150865.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ADPT"],"gpt_icon":0},{"id":"2511524052","title":"Adaptive Biotechnologies Corporation盘中异动 早盘急速上涨5.03%报7.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511524052","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511524052?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:43","pubTimestamp":1739461435,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时43分,Adaptive Biotechnologies Corporation股票出现波动,股价大幅拉升5.03%。截至发稿,该股报7.93美元/股,成交量32.835万股,换手率0.22%,振幅7.35%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中,整体涨幅为0.50%。Adaptive Biotechnologies Corporation公司简介:Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗,来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213234356a244bb18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213234356a244bb18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"2510345749","title":"美国研究综述-爱迪生国际公司、Onestream 公司、Vertex 制药公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2510345749","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510345749?lang=zh_cn&edition=full","pubTime":"2025-02-12 15:21","pubTimestamp":1739344887,"startTime":"0","endTime":"0","summary":"美国研究综述-爱迪生国际公司、Onestream 公司、Vertex 制药公司路透2月12日 - 华尔街证券分析师周三修订了对爱迪生国际、Onestream 和 Vertex Pharmaceuticals 等几家美国上市公司的评级和目标价。要点 * 爱迪生国际EIX.N:摩根大通给予其中性评级 * Molina Healthcare Inc MOH.N:摩根大通将目标价从350美元下调至333美元 * Onestream Inc OS.O:摩根大通将其评级从 \"增持 \"下调至 \"中性\"。* Vertex Pharmaceuticals Inc VRTX.O:Canaccord Genuity将其评级从 \"卖出 \"上调至 \"持有\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nL4S3P30JN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPG","VRTX","KDP","OS","ADPT","CELH","CNA","PCG","POST","INSP","KO","LH","LNC","SMCI","CG","MNST","WCC","EDR","ALSN","CFLT","VST","TVTX","PFG","COTY","MAR","L","UNM","HUM","CNO","LDOS","MET","DASH","ARI","ECL","EQH","LU2279689827.SGD","EIX","AFL","MOH","GILD","FLNC","PRU","ST","LU1066051498.USD","LYFT","BK4504","FRSH","FIS","BYD","GL"],"gpt_icon":0},{"id":"2510345742","title":"美国研究综述-爱迪生国际公司、Onestream 公司、Vertex 制药公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2510345742","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510345742?lang=zh_cn&edition=full","pubTime":"2025-02-12 15:21","pubTimestamp":1739344887,"startTime":"0","endTime":"0","summary":"美国研究综述-爱迪生国际公司、Onestream 公司、Vertex 制药公司路透2月12日 - 华尔街证券分析师周三修订了对爱迪生国际、Onestream 和 Vertex Pharmaceuticals 等几家美国上市公司的评级和目标价。要点 * 爱迪生国际EIX.N:摩根大通给予其中性评级 * Molina Healthcare Inc MOH.N:摩根大通将目标价从350美元下调至333美元 * Onestream Inc OS.O:摩根大通将其评级从 \"增持 \"下调至 \"中性\"。* Vertex Pharmaceuticals Inc VRTX.O:Canaccord Genuity将其评级从 \"卖出 \"上调至 \"持有\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nL4T3P30JN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BYD","LDOS","L","EIX","PPG","FIS","ARI","GILD","OS","LNC","COTY","LU1066051498.USD","POST","AFL","ST","ECL","PCG","CNO","CG","WCC","PFG","DASH","MNST","KDP","EQH","LH","MOH","PRU","HUM","BK4504","UNM","CNA","MAR","GL","VRTX","EDR","INSP","LYFT","TVTX","FLNC","FRSH","LU2279689827.SGD","ALSN","CFLT","ADPT","MET"],"gpt_icon":1},{"id":"2510366832","title":"Adaptive Biotechnologies 公司报告截至 12 月 31 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2510366832","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510366832?lang=zh_cn&edition=full","pubTime":"2025-02-12 06:42","pubTimestamp":1739313733,"startTime":"0","endTime":"0","summary":"Adaptive Biotechnologies 公司报告截至 12 月 31 日的季度业绩 - 收益摘要Adaptive Biotechnologies Corp ADPT.OQ报告,截至12月31日的季度调整后每股亏损23美分,高于去年同期的每股-30美分。八位分析师对该季度的平均预期是每股亏损 26 美分。Adaptive Biotechnologies 公司公布的本季度每股收益为亏损 23 美分。该公司的季度亏损额为 3369 万美元。Adaptive Biotechnologies Corp 的股价本季度上涨了 28.1%。华尔街对 Adaptive Biotechnologies Corp 的 12 个月目标价中位数为 7.50 美元。本摘要由 LSEG 2 月 11 日 10:42 p.m. UTC 调制解调器器生成。如有任何其他问题或反馈,请联系 RefinitivNewsSupport@thomsonreuters.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250211:nL4T3P21Z7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"1179443604","title":"Adaptive Biotechnologies 2024年第四季度GAAP每股亏损$(0.23)优于预期$(0.26),销售额$47.459百万超过预期$46.034百万","url":"https://stock-news.laohu8.com/highlight/detail?id=1179443604","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179443604?lang=zh_cn&edition=full","pubTime":"2025-02-12 05:12","pubTimestamp":1739308350,"startTime":"0","endTime":"0","summary":"Adaptive Biotechnologies 报告季度每股亏损$,优于分析师共识预期的$,超出11.54%。相比去年同期的$45.784百万,销售额增长了3.66%。以上内容来自Benzinga Earnings专栏,原文如下:Adaptive Biotechnologies reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 11.54 percent. The company reported quarterly sales of $47.459 million which beat the analyst consensus estimate of $46.034 million by 3.09 percent. This is a 3.66 percent increase over sales of $45.784 million the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Adaptive Biotechnologies 2024年第四季度GAAP每股亏损$(0.23)优于预期$(0.26),销售额$47.459百万超过预期$46.034百万","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADPT"],"gpt_icon":0},{"id":"2510869382","title":"Adaptive Biotechnologies Corporation盘中异动 股价大跌5.31%报7.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510869382","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510869382?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:05","pubTimestamp":1739199908,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日23时05分,Adaptive Biotechnologies Corporation股票出现异动,股价急速下跌5.31%。截至发稿,该股报7.42美元/股,成交量26.2473万股,换手率0.18%,振幅5.35%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中,整体涨幅为0.27%。Adaptive Biotechnologies Corporation公司简介:Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗,来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210230509961e0735&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210230509961e0735&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"2509960287","title":"Adaptive Biotechnologies Corporation盘中异动 快速上涨5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509960287","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509960287?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:51","pubTimestamp":1738767095,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日22时51分,Adaptive Biotechnologies Corporation股票出现异动,股价急速拉升5.29%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中,整体涨幅为1.60%。其相关个股中,Oragenics Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Pasithea Therapeutics Corp.涨幅较大,Pasithea Therapeutics Corp.、Oragenics Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃,换手率分别为3540.20%、1029.52%、654.81%,振幅较大的相关个股有Oragenics Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Pasithea Therapeutics Corp.,振幅分别为59.80%、54.05%、37.50%。Adaptive Biotechnologies Corporation公司简介:Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗,来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205225135a23a7f68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205225135a23a7f68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT","BK4121"],"gpt_icon":0},{"id":"2509288495","title":"Adaptive Biotechnologies Corporation盘中异动 下午盘急速下跌5.00%报7.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509288495","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509288495?lang=zh_cn&edition=full","pubTime":"2025-02-05 03:59","pubTimestamp":1738699153,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日03时59分,Adaptive Biotechnologies Corporation股票出现波动,股价快速下跌5.00%。截至发稿,该股报7.32美元/股,成交量52.3545万股,换手率0.35%,振幅7.14%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中,整体涨幅为1.56%。Adaptive Biotechnologies Corporation公司简介:Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗,来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205035914a2396533&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205035914a2396533&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"2507262907","title":"Adaptive Biotechnologies Corporation盘中异动 股价大涨5.19%报8.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507262907","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507262907?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:35","pubTimestamp":1738247711,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时35分,Adaptive Biotechnologies Corporation股票出现异动,股价大幅拉升5.19%。截至发稿,该股报8.11美元/股,成交量1.5705万股,换手率0.01%,振幅1.82%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中,整体涨幅为0.01%。Adaptive Biotechnologies Corporation公司简介:Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗,来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223511abbd4d0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223511abbd4d0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT","BK4121"],"gpt_icon":0},{"id":"2507925652","title":"Adaptive Biotechnologies Corporation盘中异动 股价大跌5.03%报7.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507925652","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507925652?lang=zh_cn&edition=full","pubTime":"2025-01-30 03:17","pubTimestamp":1738178267,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日03时17分,Adaptive Biotechnologies Corporation股票出现异动,股价大幅跳水5.03%。截至发稿,该股报7.46美元/股,成交量49.7362万股,换手率0.34%,振幅7.52%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中,整体涨幅为1.02%。Adaptive Biotechnologies Corporation公司简介:Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗,来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130031747a2339612&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130031747a2339612&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"2506510985","title":"高盛:维持Adaptive Biotechnologies(ADPT.US)评级,由中性调整至中性评级, 目标价由5.50美元调整至7.50美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2506510985","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506510985?lang=zh_cn&edition=full","pubTime":"2025-01-28 23:33","pubTimestamp":1738078416,"startTime":"0","endTime":"0","summary":"高盛:维持Adaptive Biotechnologies(ADPT.US)评级,由中性调整至中性评级, 目标价由5.50美元调整至7.50美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/28233347883253.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ADPT"],"gpt_icon":0},{"id":"2506811185","title":"Adaptive Biotechnologies Corporation盘中异动 快速跳水5.01%报7.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506811185","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506811185?lang=zh_cn&edition=full","pubTime":"2025-01-28 03:52","pubTimestamp":1738007547,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日03时52分,Adaptive Biotechnologies Corporation股票出现异动,股价大幅下跌5.01%。截至发稿,该股报7.59美元/股,成交量44.601万股,换手率0.30%,振幅6.95%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中,整体涨幅为0.75%。Adaptive Biotechnologies Corporation公司简介:Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗,来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128035228961267ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128035228961267ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"2505729048","title":"Adaptive Biotechnologies Corporation盘中异动 早盘急速拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505729048","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505729048?lang=zh_cn&edition=full","pubTime":"2025-01-22 22:48","pubTimestamp":1737557321,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日22时48分,Adaptive Biotechnologies Corporation股票出现异动,股价快速上涨5.10%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中,整体涨幅为0.18%。Adaptive Biotechnologies Corporation公司简介:Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗,来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122224841abb4aa24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122224841abb4aa24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT","BK4121"],"gpt_icon":0},{"id":"2505279061","title":"Adaptive Biotechnologies Corporation盘中异动 股价大涨5.51%报7.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505279061","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505279061?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:32","pubTimestamp":1737469923,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时32分,Adaptive Biotechnologies Corporation股票出现波动,股价快速上涨5.51%。截至发稿,该股报7.19美元/股,成交量3.3492万股,换手率0.02%,振幅3.08%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中,整体涨幅为0.81%。Adaptive Biotechnologies Corporation公司简介:Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗,来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223203960bb8fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223203960bb8fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"2503919289","title":"Adaptive Biotechnologies Corporation盘中异动 快速下挫5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503919289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503919289?lang=zh_cn&edition=full","pubTime":"2025-01-16 23:40","pubTimestamp":1737042001,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日23时40分,Adaptive Biotechnologies Corporation股票出现异动,股价大幅下挫5.31%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中,整体跌幅为0.57%。Adaptive Biotechnologies Corporation公司简介:Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗,来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011623400198689b12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011623400198689b12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT","BK4121"],"gpt_icon":0},{"id":"2503647457","title":"Adaptive Biotechnologies Corporation盘中异动 大幅上涨8.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503647457","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503647457?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:33","pubTimestamp":1736951633,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时33分,Adaptive Biotechnologies Corporation股票出现异动,股价快速拉升8.57%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中,整体涨幅为0.84%。其相关个股中,Exicure, Inc.、Allovir, Inc.、Monte Rosa Therapeutics, Inc.涨幅较大,Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃,换手率分别为185.76%、57.75%、35.59%,振幅较大的相关个股有Onconetix, Inc.、Eterna Therapeutics Inc.、Klotho Neurosciences, Inc.,振幅分别为14.29%、12.79%、12.00%。Adaptive Biotechnologies Corporation公司简介:Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗,来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223353ababf321&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223353ababf321&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"2503685865","title":"Adaptive Biotechnologies Corporation盘中异动 下午盘股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503685865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503685865?lang=zh_cn&edition=full","pubTime":"2025-01-15 03:38","pubTimestamp":1736883517,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日03时38分,Adaptive Biotechnologies Corporation股票出现异动,股价快速跳水5.11%。截至发稿,该股报6.13美元/股,成交量47.1365万股,换手率0.32%,振幅7.86%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中,整体跌幅为0.58%。Adaptive Biotechnologies Corporation公司简介:Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗,来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115033838abaaeee3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115033838abaaeee3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"2503538583","title":"Adaptive Biotechnologies Corporation盘中异动 临近午盘快速下跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503538583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503538583?lang=zh_cn&edition=full","pubTime":"2025-01-14 00:49","pubTimestamp":1736786995,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日00时49分,Adaptive Biotechnologies Corporation股票出现波动,股价大幅下跌5.08%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中,整体跌幅为0.48%。其相关个股中,Phio Pharmaceuticals Corp.、Kairos Pharma, Ltd.、Salarius Pharmaceuticals, Inc.涨幅较大,Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.较为活跃,换手率分别为12133.90%、6793.50%、541.81%,振幅较大的相关个股有Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.,振幅分别为336.09%、216.61%、201.86%。Adaptive Biotechnologies Corporation公司简介:Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗,来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114004956a220605a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114004956a220605a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.adaptivebiotech.com","stockEarnings":[{"period":"1week","weight":0.0625},{"period":"1month","weight":0.1634},{"period":"3month","weight":0.6398},{"period":"6month","weight":0.7246},{"period":"1year","weight":1.1035},{"period":"ytd","weight":0.3895}],"compareEarnings":[{"period":"1week","weight":0.0149},{"period":"1month","weight":0.0285},{"period":"3month","weight":0.0409},{"period":"6month","weight":0.0999},{"period":"1year","weight":0.2145},{"period":"ytd","weight":0.0403}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Adaptive Biotechnologies Corporation于2009年9月8日在华盛顿州注册成立。公司正通过利用适应性免疫系统的固有生物学,向疾病的诊断和治疗转变,推进免疫驱动医学领域。该公司认为,适应性免疫系统是大自然对大多数疾病进行的最精细的诊断和治疗,但无法解码使医学界无法充分利用其能力。该公司的免疫医学平台应用专有技术来读取患者免疫系统的多种遗传密码,并准确了解如何检测和治疗该患者的疾病。该公司的免疫医学平台应用专有技术来读取患者免疫系统的多种遗传密码,并准确了解如何检测和治疗该患者的疾病。该公司在动态临床免疫组学数据库中捕捉到这些见解,该数据库以计算生物学和机器学习为基础,用于开发和商业化公司正在为每位患者量身定制的临床产品和服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.030966},{"month":2,"riseRate":0.5,"avgChangeRate":-0.01601},{"month":3,"riseRate":0.2,"avgChangeRate":-0.104809},{"month":4,"riseRate":0.4,"avgChangeRate":-0.119052},{"month":5,"riseRate":0.4,"avgChangeRate":0.071471},{"month":6,"riseRate":0.8,"avgChangeRate":0.075735},{"month":7,"riseRate":0.5,"avgChangeRate":0.018955},{"month":8,"riseRate":0.5,"avgChangeRate":0.038941},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.099197},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.062214},{"month":11,"riseRate":0.666667,"avgChangeRate":0.035467},{"month":12,"riseRate":0.833333,"avgChangeRate":0.066718}],"exchange":"NASDAQ","name":"Adaptive Biotechnologies Corp","nameEN":"Adaptive Biotechnologies Corp"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.30.2","shortVersion":"4.30.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Adaptive Biotechnologies Corp(ADPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Adaptive Biotechnologies Corp(ADPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Adaptive Biotechnologies Corp,ADPT,Adaptive Biotechnologies Corp股票,Adaptive Biotechnologies Corp股票老虎,Adaptive Biotechnologies Corp股票老虎国际,Adaptive Biotechnologies Corp行情,Adaptive Biotechnologies Corp股票行情,Adaptive Biotechnologies Corp股价,Adaptive Biotechnologies Corp股市,Adaptive Biotechnologies Corp股票价格,Adaptive Biotechnologies Corp股票交易,Adaptive Biotechnologies Corp股票购买,Adaptive Biotechnologies Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Adaptive Biotechnologies Corp(ADPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Adaptive Biotechnologies Corp(ADPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}